COVID-19. Alternativas terapéuticas
References
2. Liu Y, Li J, Feng Y. Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China. Crit Care [Internet]. 2020 [citado 2020 Mar 25];24:56 Disponible en: https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-2786
3. Guangdi Li, Erik De Clercq. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature reviews [Internet]. 2020 [citado 2020 Mar 25]; 19:149-150. Disponible en: https://doi.org/10.1038/d41573-020-00016-0
4. Wu J, Li W, Shi X, Chen Z, Jiang B, Liu J, et al. Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19). J. Intern Med. [Internet]. 2020 [citado 2020 Mar 25]. Disponible en: https://doi.org/10.1111/joim.13063
5. Zhang C, Huang S, Zheng F, Dai Y. Controversial treatments: an updated understanding of the Coronavirus Disease 2019. J Med Virol. [Internet]. 2020 [citado 2020 Mar 25]. Disponible en: https://doi.org/10.1002/jmv.25788
6. ISCIII, Comunicado. Primeros ensayos financiados por el Fondo COVID-19 del ISCIII: terapia precoz en combinación y plasma de pacientes recuperados. [Internet]. 2020 [citado 2020 Mar 25]. Disponible en: https://www.isciii.es/Noticias/Noticias/Paginas/Noticias/PrimerosEnsayosFondoCOVID19.aspx
7. Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. [Internet]. 2020 [citado 2020 Mar 25]; 130(4): 1545-48. Disponible en: https://doi.org/10.1172/JCI138003
Downloads
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal, accept the following terms:
The authors will retain their copyright and guarantee the journal the right of first publication of your work, which will be under a Creative license Commons Attribution-NonCommercial-ShareAlike 4.0 International . (CC BY-NC-SA 4.0).
The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (eg:deposit it in an institutional telemat